| For: | Razok A, Ata F, Ahmed SMI, Al Mohanadi DHSH. Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation. World J Diabetes 2022; 13(3): 272-274 [PMID: 35432760 DOI: 10.4239/wjd.v13.i3.272] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i3/272.htm |
| Number | Citing Articles |
| 1 |
Yiwei Huang, Xinyuan Yu, Changxin Li. Sodium–Glucose Cotransporter 2 Inhibitors: An Emerging Therapeutic Approach for Ischemic Stroke Management. CNS Drugs 2025; 39(12): 1273 doi: 10.1007/s40263-025-01230-3
|
| 2 |
Nenad Lakušić, Ivana Sopek Merkaš, Ana Marija Slišković, Dora Cerovec. Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors. World Journal of Cardiology 2022; 14(10): 561-564 doi: 10.4330/wjc.v14.i10.561
Abstract(930) |
Core Tip(741) |
Full Article(HTML)(2361)
|
Full Article (PDF)-1882K(390)
|
Full Article (Word)-106K(53)
|
Audio-325K(11)
|
Peer-Review Report-244K(98)
|
Answering Reviewers-207K(92)
|
Times Cited (0)
|
Total Visits (7842)
|
Open
|
| 3 |
|
